EcoDrugPlus

Cathepsin K

Ensembl ID : ENSPFOG00000007832
Gene Symbol: LOC103156711
3 Cross references
222 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSPFOG00000007895
Gene Symbol: LOC103156712
3 Cross references
233 Possible Orthologues:

Cell Division Cycle 7 Homolog (S. Cerevisiae)

Ensembl ID : ENSPFOG00000017217
Gene Symbol: CDC7
1 Cross references
207 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSPFOG00000018605
Gene Symbol: CHEK1
3 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSPFOG00000011753
Gene Symbol: CHEK2
3 Cross references
205 Possible Orthologues:

Chemokine (C-C Motif) Receptor 9a

Ensembl ID : ENSPFOG00000011293
Gene Symbol: CCR9A
1 Cross references
188 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSPFOG00000011947
Gene Symbol: CCKAR
4 Cross references
200 Possible Orthologues:

Cholecystokinin Receptor Type A-Like

Ensembl ID : ENSPFOG00000010838
Gene Symbol: LOC103140396
2 Cross references
191 Possible Orthologues:

Cholecystokinin Receptor-Like

Ensembl ID : ENSPFOG00000000880
Gene Symbol: LOC103155842
3 Cross references
193 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSPFOG00000003174
Gene Symbol: LOC103147688
2 Cross references
252 Possible Orthologues:

Cholesteryl Ester Transfer Protein

Ensembl ID : ENSPFOG00000006371
Gene Symbol: CETP
3 Cross references
137 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSPFOG00000020920
Gene Symbol: CHRM3
3 Cross references
187 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).